CN103275134A - Method for extracting phyllanthus niruri glycoside from phyllanthus niruri - Google Patents

Method for extracting phyllanthus niruri glycoside from phyllanthus niruri Download PDF

Info

Publication number
CN103275134A
CN103275134A CN 201310194380 CN201310194380A CN103275134A CN 103275134 A CN103275134 A CN 103275134A CN 201310194380 CN201310194380 CN 201310194380 CN 201310194380 A CN201310194380 A CN 201310194380A CN 103275134 A CN103275134 A CN 103275134A
Authority
CN
China
Prior art keywords
methanol solution
herba scopariae
phyllanthus niruri
extract
glycosides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 201310194380
Other languages
Chinese (zh)
Inventor
刘东锋
杨成东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Zelang Medical Technology Co Ltd
Original Assignee
Nanjing Zelang Medical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Zelang Medical Technology Co Ltd filed Critical Nanjing Zelang Medical Technology Co Ltd
Priority to CN 201310194380 priority Critical patent/CN103275134A/en
Publication of CN103275134A publication Critical patent/CN103275134A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a method for extracting phyllanthus niruri glycoside from phyllanthus niruri. The method is simple in operation and low in pollution and comprises the following steps of: (1) crushing medicinal phyllanthus niruri materials, adding 80-90% methanol solution which is 5-10 times that of the crushed medicinal phyllanthus niruri materials in volume, carrying out ultrasonic extraction for 2-3 times, concentrating extract, adding water to the concentrated extract so as to disperse the concentrated extract, filtering, adding filtrate in macroporous resin so as to carry out adsorption, carrying out gradient elution by using a methanol solution, and concentrating eluate so as to obtain concentrate; and (2) extracting the concentrate for 2-3 times by using a n-butanol solution, recovering n-butanol from extract, then diluting the extract by using water, adding the diluted extract into an ODS (Oxide Dispersion Strengthened) column for adsorption, eluting by using a 30% methanol solution, carrying out thin-layer detection, collecting fractions, and drying under reduced pressure, thereby obtaining the phyllanthus niruri glycoside. By adopting the method for extracting the phyllanthus niruri glycoside, the purity of the obtained product is high, and the industrialized amplification is easy to realize.

Description

A kind of from Herba Scopariae the method for purification Herba Scopariae glycosides
Technical field
The invention belongs to the Natural Medicine Chemistry field, relate to a kind of from Herba Scopariae the method for purification Herba Scopariae glycosides.
Background technology
Herba Scopariae is Euphorbiaceae (Euphorbiaceae) plant Herba Scopariae Phyllanthus niruriL is a kind of widely distributed medicinal plant, hepatitis and the urinary stone disease of being used for the treatment of among the people.Modern study is found, contains type compounds such as flavonoid, phenylpropyl alcohol chlorins compound in the Herba Scopariae, have antiviral, protect the liver, angiotensin-converting enzyme suppresses and effect such as immunosuppression.
The Herba Scopariae glycosides is the plain glycoside material of the phenylpropyl alcohol in the Herba Scopariae, white amorphous powder, and molecular formula is C 38H 42O 17, molecular weight is 770.74, molecular structural formula is:
Figure 2013101943802100002DEST_PATH_IMAGE002
Modern pharmacological research shows that the Herba Scopariae glycosides has anti-HIV effect, suppress to be denoted as [ 33P] combination of RRE (REV-responsive element) RNA and HIV-REV (regulation of virion expression) albumen, its IC 50Being 3.3 μ M, is special HIV-REV albumen/RRE RNA inhibitor.
By literature search, the method for purification Herba Scopariae glycosides discloses less from Herba Scopariae.
Summary of the invention
The technical problem to be solved in the present invention provides a kind of method of easy and simple to handle, product purity is high from Herba Scopariae purification Herba Scopariae glycosides.
For achieving the above object, the present invention is by the following technical solutions:
A kind of from Herba Scopariae the method for purification Herba Scopariae glycosides, it is characterized in that may further comprise the steps:
1) get the Herba Scopariae pulverizing medicinal materials, add 5-10 and doubly measure 80-90% methanol solution supersound extraction 2-3 time, extracting solution concentrates and adds water-dispersion, filters, add in the macroporous resin again and adsorb, the methanol solution gradient elution, elutriant concentrated concentrated solution;
2) above-mentioned concentrated solution extracts 2-3 time with butanol solution, and dilute with water behind the extraction liquid recovery propyl carbinol adds in the ODS post and adsorbs, 30% methanol solution wash-out, and thin layer detects, and collects the flow point drying under reduced pressure and namely gets the Herba Scopariae glycosides.
Described macroporous resin model is: AB-8, ADS-21, HZ-818, NK-9.
Described methanol solution gradient elution is: 3-5 times of column volume 10-30% methanol solution wash-out impurity, 4-6 times of column volume 40-70% methanol solution wash-out effective constituent.
Adopt present method purification Herba Scopariae glycosides, technology is simple to operation, pollute little, products obtained therefrom purity height.
Further specify the present invention below in conjunction with embodiment, but the scope of protection of present invention is not limited to following embodiment.
Embodiment:
Embodiment 1:
Herba Scopariae 5kg pulverizes, and gets the extractor jar, adds 50kg80% methanol solution supersound extraction 30 minutes, extract 2 times, the united extraction concentrating under reduced pressure adds behind the concentrated solution dilute with water in the 3L AB-8 macroporous resin column and adsorbs, flow velocity 20ml/min, behind the last sample, with 10L 10% methanol solution wash-out impurity, use 15L50% methanol solution wash-out effective constituent again, collect the elutriant concentrating under reduced pressure, get concentrated solution 800ml, add the extraction of 1600ml butanol solution, extract 2 times, the extraction liquid concentrating under reduced pressure, the concentrated solution dilute with water adds to be equipped with in the 100gODS resin column and adsorbs flow rate control 3ml/min, end of the sample, get 30% methanol solution wash-out, thin layer detects, the Fractional Collections flow point, with high density flow point concentrating under reduced pressure drying, get Herba Scopariae glycosides 3.1g, detect content 98.5% through HPLC.
Embodiment 2:
Herba Scopariae 5kg pulverizes, and gets the extractor jar, adds 30kg80% methanol solution supersound extraction 30 minutes, extract 3 times, the united extraction concentrating under reduced pressure adds behind the concentrated solution dilute with water in the 3L ADS-21 macroporous resin column and adsorbs, flow velocity 30ml/min, behind the last sample, with 12L 20% methanol solution wash-out impurity, use 15L60% methanol solution wash-out effective constituent again, collect the elutriant concentrating under reduced pressure, get concentrated solution 700ml, add the extraction of 1000ml butanol solution, extract 3 times, the extraction liquid concentrating under reduced pressure, the concentrated solution dilute with water adds to be equipped with in the 100gODS resin column and adsorbs flow rate control 2ml/min, end of the sample, get 30% methanol solution wash-out, thin layer detects, the Fractional Collections flow point, with high density flow point concentrating under reduced pressure drying, get Herba Scopariae glycosides 3.8g, detect content 98.8% through HPLC.
Embodiment 3:
Herba Scopariae 5kg pulverizes, and gets the extractor jar, adds 50kg90% methanol solution supersound extraction 30 minutes, extract 2 times, the united extraction concentrating under reduced pressure adds behind the concentrated solution dilute with water in the 3L HZ-818 macroporous resin column and adsorbs, flow velocity 20ml/min, behind the last sample, with 10L30% methanol solution wash-out impurity, use 12L60% methanol solution wash-out effective constituent again, collect the elutriant concentrating under reduced pressure, get concentrated solution 600ml, add the extraction of 900ml butanol solution, extract 3 times, the extraction liquid concentrating under reduced pressure, the concentrated solution dilute with water adds to be equipped with in the 100gODS resin column and adsorbs flow rate control 3ml/min, end of the sample, get 30% methanol solution wash-out, thin layer detects, the Fractional Collections flow point, with high density flow point concentrating under reduced pressure drying, get Herba Scopariae glycosides 3.9g, detect content 97.1% through HPLC.
Embodiment 4:
Herba Scopariae 5kg pulverizes, and gets the extractor jar, adds 25kg90% methanol solution supersound extraction 30 minutes, extract 3 times, the united extraction concentrating under reduced pressure adds behind the concentrated solution dilute with water in the 3L NK-9 macroporous resin column and adsorbs, flow velocity 25ml/min, behind the last sample, with 10L 30% methanol solution wash-out impurity, use 20L50% methanol solution wash-out effective constituent again, collect the elutriant concentrating under reduced pressure, get concentrated solution 1000ml, add the extraction of 2000ml butanol solution, extract 2 times, the extraction liquid concentrating under reduced pressure, the concentrated solution dilute with water adds to be equipped with in the 100gODS resin column and adsorbs flow rate control 2ml/min, end of the sample, get 30% methanol solution wash-out, thin layer detects, the Fractional Collections flow point, with high density flow point concentrating under reduced pressure drying, get Herba Scopariae glycosides 4.1g, detect content 98.1% through HPLC.

Claims (3)

1. the method for a purification Herba Scopariae glycosides from Herba Scopariae is characterized in that may further comprise the steps:
1) get the Herba Scopariae pulverizing medicinal materials, add 5-10 and doubly measure 80-90% methanol solution supersound extraction 2-3 time, extracting solution concentrates and adds water-dispersion, filters, add in the macroporous resin again and adsorb, the methanol solution gradient elution, elutriant concentrated concentrated solution;
2) above-mentioned concentrated solution extracts 2-3 time with butanol solution, and dilute with water behind the extraction liquid recovery propyl carbinol adds in the ODS post and adsorbs, 30% methanol solution wash-out, and thin layer detects, and collects the flow point drying under reduced pressure and namely gets the Herba Scopariae glycosides.
As claimed in claim 1 from Herba Scopariae the method for purification Herba Scopariae glycosides, it is characterized in that the macroporous resin model described in the step 1) is: AB-8, ADS-21, HZ-818, NK-9.
As claimed in claim 1 from Herba Scopariae the method for purification Herba Scopariae glycosides, it is characterized in that the gradient elution of methanol solution described in the step 1) is: 3-5 times of column volume 10-30% methanol solution wash-out impurity, 4-6 times of column volume 40-70% methanol solution wash-out effective constituent.
CN 201310194380 2013-05-23 2013-05-23 Method for extracting phyllanthus niruri glycoside from phyllanthus niruri Pending CN103275134A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201310194380 CN103275134A (en) 2013-05-23 2013-05-23 Method for extracting phyllanthus niruri glycoside from phyllanthus niruri

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201310194380 CN103275134A (en) 2013-05-23 2013-05-23 Method for extracting phyllanthus niruri glycoside from phyllanthus niruri

Publications (1)

Publication Number Publication Date
CN103275134A true CN103275134A (en) 2013-09-04

Family

ID=49057777

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201310194380 Pending CN103275134A (en) 2013-05-23 2013-05-23 Method for extracting phyllanthus niruri glycoside from phyllanthus niruri

Country Status (1)

Country Link
CN (1) CN103275134A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106333988A (en) * 2016-09-30 2017-01-18 安徽华澳生物技术有限公司 Preparation method and application of bitter phyllanchus amarus extract

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106333988A (en) * 2016-09-30 2017-01-18 安徽华澳生物技术有限公司 Preparation method and application of bitter phyllanchus amarus extract

Similar Documents

Publication Publication Date Title
CN102276679B (en) Method for extracting high-purity tea saponin from oil-tea-cake by decompression boiling
CN101130548A (en) Method for extracting and producing high content arteannuin
CN102617468A (en) Method for ultrasound-assisted extraction of lappaconitine
CN103214533A (en) Method for continuously preparing cordycepin and cordyceps polysaccharide by using membrane separation technology
CN103694364A (en) Method for synchronously extracting, separating and purifying polysaccharides and flavones of cyclocarya paliurus
CN101168537A (en) Method for simultaneously preparing andrographolide and dehydrated andrographolide
CN101525328B (en) Method for extracting alpha-mangostin from mangosteen fruit peel
CN103408610A (en) Method for extracting arbutin from pear leaves
CN103265554A (en) Preparation method of demethylwedelolactone
CN107298687A (en) Purification maackiain technique is extracted from beautiful millettia root
CN103265521A (en) Preparation method of demethylated beilidifolin
CN103275134A (en) Method for extracting phyllanthus niruri glycoside from phyllanthus niruri
CN108997359A (en) A method of chlorophyll is extracted from stevioside production waste residue
CN106986904A (en) A kind of Gastrodin extracted in the anesthesia stem from day and preparation method thereof
CN103408615A (en) Preparation method for chemical reference substance of sweroside in Tibetan capillary artemisia medicinal material
CN104473981B (en) A kind of isolation and purification method of high-purity autumn eggplant leaf flavonoids
CN104072570A (en) Preparation method of momordin Ic
CN102250183A (en) Method for preparing high-purity ginsenoside Re by using ginseng flower buds as raw materials
CN104711312B (en) The method that Astragaloside IV is prepared using Trichoderma viride
CN106943442B (en) Antiviral traditional Chinese medicine extract and preparation method thereof
CN101879265A (en) Process for co-producing total saponins and polysaccharide from star-of-Bethlehem
CN103275144A (en) Method for preparing acteoside from rehmannia leaves
CN103450315A (en) Preparation method of sliver-white aglaione A
CN103739649A (en) Preparation method for mussaendoside G
CN103709213B (en) A kind of processing method of extraction purification TSG from Tuber Fleeceflower Root

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130904